Table of Contents
Metal-Based Drugs
Volume 2011 (2011), Article ID 763436, 10 pages
http://dx.doi.org/10.1155/2011/763436
Research Article

Mutagenic Tests Confirm That New Acetylacetonate Pt(II) Complexes Induce Apoptosis in Cancer Cells Interacting with Nongenomic Biological Targets

Dipartimento di Scienze e Tecnologie Biologiche ed Ambientali, Università del Salento, Prov. le Lecce/Monteroni, 73100 Lecce, Italy

Received 30 July 2010; Revised 17 January 2011; Accepted 24 January 2011

Academic Editor: Giovanni Natile

Copyright © 2011 Sandra Angelica De Pascali et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Eastman, 30 Years of Cisplatin: Chemistry and Biochemistry of a Leading Anticancer Drug, Helvetica Acta; Wiley-VCH, Zurich, Switzerland, 1999, B. Lippert, Ed.
  2. S. Ahmad, A. A. Isab, and S. Ali, “Structural and mechanistic aspects of platinum anticancer agents,” Transition Metal Chemistry, vol. 31, no. 8, pp. 1003–1016, 2006. View at Publisher · View at Google Scholar
  3. Y. Mantri, S. J. Lippard, and M. H. Baik, “Bifunctional binding of cisplatin to DNA: why does cisplatin form 1,2-intrastrand cross-links with AG but not with GA?” Journal of the American Chemical Society, vol. 129, no. 16, pp. 5023–5030, 2007. View at Publisher · View at Google Scholar · View at PubMed
  4. N. Summa, W. Schiessl, R. Puchta, N. Van Eikema Hommes, and R. Van Eldik, “Thermodynamic and kinetic studies on reactions of Pt(II) complexes with biologically relevant nucleophiles,” Inorganic Chemistry, vol. 45, no. 7, pp. 2948–2959, 2006. View at Publisher · View at Google Scholar · View at PubMed
  5. M. Benedetti, C. Ducani, D. Migoni et al., “Experimental evidence that a DNA polymerase can incorporate N7-platinated guanines to give platinated DNA,” Angewandte Chemie—International Edition, vol. 47, no. 3, pp. 507–510, 2008. View at Publisher · View at Google Scholar · View at PubMed
  6. J. Reedijk, “Why does cisplatin reach guanine-N7 with competing S-donor ligands available in the cell?” Chemical Reviews, vol. 99, no. 9, pp. 2499–2510, 1999. View at Google Scholar
  7. A. R. Timerbaev, C. G. Hartinger, S. S. Aleksenko, and B. K. Keppler, “Interactions of antitumor metallodrugs with serum proteins: advances in characterization using modern analytical methodology,” Chemical Reviews, vol. 106, no. 6, pp. 2224–2248, 2006. View at Publisher · View at Google Scholar · View at PubMed
  8. P. J. Sadler, “Inorganic chemistry and drug design,” Advances in Inorganic Chemistry, vol. 36, pp. 1–48, 1991. View at Google Scholar
  9. E. L. M. Lempers and J. Reedijk, “Interactions of platinum amine compounds with sulfur-containing biomolecules and DNA fragments,” Advances in Inorganic Chemistry, vol. 37, pp. 175–217, 1991. View at Publisher · View at Google Scholar
  10. D. Wang and S. J. Lippard, “Cellular processing of platinum anticancer drugs,” Nature Reviews Drug Discovery, vol. 4, no. 4, pp. 307–320, 2005. View at Publisher · View at Google Scholar · View at PubMed
  11. P. J. O’Dwier, J. P. Stevenson, and S. W. Johnson, Cisplatin: Chemistry and Biochemistry of a Leading Anticancer Drugs, Helvetica Acta; Wiley-VCH, Zurich, Switzerland, 1991, B. Lippert, Ed.
  12. M. A. Fuertes, J. Castilla, C. Alonso, and J. M. Pérez, “Cisplatin biochemical mechanism of action: from cytotoxity to induction of cell death through interconnections between apoptotic and necrotic pathways,” Current Medicinal Chemistry, vol. 10, no. 3, pp. 257–266, 2003. View at Google Scholar
  13. V. M. Gonzalez, M. A. Fuertes, C. Alonso, and J. M. Perez, “Is cisplatin-induced cell death always produced by apoptosis?” Molecular Pharmacology, vol. 59, no. 4, pp. 657–663, 2001. View at Google Scholar
  14. R. P. Perez, “Cellular and molecular determinants of cisplatin resistance,” European Journal of Cancer, vol. 34, no. 10, pp. 1535–1542, 1998. View at Publisher · View at Google Scholar
  15. A. Muscella, L. Urso, N. Calabriso et al., “Differential response of normal, dedifferentiated and transformed thyroid cell lines to cisplatin treatment,” Biochemical Pharmacology, vol. 71, no. 1-2, pp. 50–60, 2005. View at Publisher · View at Google Scholar · View at PubMed
  16. L. Urso, A. Muscella, N. Calabriso et al., “Differential functions of PKC-δ and PKC-ζ in cisplatin response of normal and transformed thyroid cells,” Biochemical and Biophysical Research Communications, vol. 337, no. 1, pp. 297–305, 2005. View at Publisher · View at Google Scholar · View at PubMed
  17. S. A. De Pascali, D. Migoni, P. Papadia et al., “New mononuclear and homodinuclear Pt(II) complexes with heterocyclic nitrogen chelates: synthesis, characterization, intercalating ability and in vitro cytotoxic activity evaluation,” Dalton Transactions, no. 43, pp. 5911–5921, 2008. View at Publisher · View at Google Scholar · View at PubMed
  18. V. M. Vecchio, M. Benedetti, D. Migoni et al., “Highly selective metal mediated ortho-alkylation of phenol. First platinum containing organometallic chromane analogues,” Dalton Transactions, no. 48, pp. 5720–5725, 2007. View at Publisher · View at Google Scholar · View at PubMed
  19. S. A. De Pascali, D. Migoni, P. Papadia et al., “New water-soluble platinum(II) phenanthroline complexes tested as cisplatin analogues: first-time comparison of cytotoxic activity between analogous four- and five-coordinate species,” Dalton Transactions, no. 42, pp. 5077–5087, 2006. View at Publisher · View at Google Scholar · View at PubMed
  20. S. A. De Pascali, P. Papadia, A. Ciccarese, C. Pacifico, and F. P. Fanizzi, “First examples of β-diketonate platinum(II) complexes with sulfoxide ligands,” European Journal of Inorganic Chemistry, no. 4, pp. 788–796, 2005. View at Publisher · View at Google Scholar
  21. A. Muscella, N. Calabriso, S. A. De Pascali et al., “New platinum(II) complexes containing both an O,O′-chelated acetylacetonate ligand and a sulfur ligand in the platinum coordination sphere induce apoptosis in HeLa cervical carcinoma cells,” Biochemical Pharmacology, vol. 74, no. 1, pp. 28–40, 2007. View at Publisher · View at Google Scholar · View at PubMed
  22. A. Muscella, N. Calabriso, F. P. Fanizzi et al., “[Pt(O,O′-acac)(γ-acac)(DMS)], a new Pt compound exerting fast cytotoxicity in MCF-7 breast cancer cells via the mitochondrial apoptotic pathway,” British Journal of Pharmacology, vol. 153, no. 1, pp. 34–49, 2008. View at Publisher · View at Google Scholar · View at PubMed
  23. S. A. De Pascali, P. Papadia, S. Capoccia et al., “Hard/soft selectivity in ligand substitution reactions of β-diketonate platinum(II) complexes,” Dalton Transactions, no. 37, pp. 7786–7795, 2009. View at Publisher · View at Google Scholar · View at PubMed
  24. A. Muscella, N. Calabriso, C. Vetrugno et al., “Sublethal concentrations of the platinum(II) complex [Pt(O,O′-acac) (γ-acac)(DMS)] alter the motility and induce anoikis in MCF-7 cells,” British Journal of Pharmacology, vol. 160, no. 6, pp. 1362–1377, 2010. View at Publisher · View at Google Scholar · View at PubMed
  25. B. N. Ames, J. McCann, and E. Yamasaki, “Methods for detecting carcinogens and mutagens with the Salmonella/mammalian microsome mutagenicity test,” Mutation Research, vol. 31, no. 6, pp. 347–364, 1975. View at Google Scholar
  26. K. Mortelmans and E. Zeiger, “The Ames Salmonella/microsome mutagenicity assay,” Mutation Research, vol. 455, no. 1-2, pp. 29–60, 2000. View at Publisher · View at Google Scholar
  27. R. K. Harris, E. D. Becker, S. M. Cabral De Menezes, R. Goodfellow, and P. Granger, “NMR nomenclature. Nuclear spin properties and conventions for chemical shifts (IUPAC recommendations 2001),” Pure and Applied Chemistry, vol. 73, no. 11, pp. 1795–1818, 2001. View at Google Scholar
  28. Y. N. Kukushkin, Y. E. Vyaz’menskii, L. I. Zorina, and Y. L. Pazukhina, “Complexes of palladium and platinum with dimethyl sulfoxide,” Russian Jounal of Inorganic Chemistry, vol. 13, pp. 835–838, 1968. View at Google Scholar
  29. Y. N. Kukushkin, Y. E. Vyaz’menskii, and L. I. Zorina, “Trans effect of dimethylsulfoxide in platinum(II) complexes,” Russian Jounal of Inorganic Chemistry, vol. 13, pp. 1573–1576, 1968. View at Google Scholar
  30. D. M. Maron and B. N. Ames, “Revised methods for the Salmonella mutagenicity test,” Mutation Research, vol. 113, no. 3-4, pp. 173–215, 1983. View at Google Scholar
  31. H. J. Vogel and D. M. Bonner, “Acetylornithinase of Escherichia coli: partial purification and some properties,” The Journal of Biological Chemistry, vol. 218, no. 1, pp. 97–106, 1956. View at Google Scholar
  32. F. P. Fanizzi, F. P. Intini, L. Maresca et al., “Biological activity of platinum complexes containing chiral centers on the nitrogen or carbon atoms of a chelate diamine ring,” Inorganica Chimica Acta, vol. 137, no. 1-2, pp. 45–51, 1987. View at Google Scholar
  33. M. Collucia, M. Correale, D. Giordano et al., “Mutagenic activity of some platinum complexes with monodentate and bidentate amines,” Inorganica Chimica Acta, vol. 123, no. 4, pp. 225–229, 1986. View at Google Scholar
  34. S. Cerri, V. M. Piccolini, G. Santin et al., “The developmental neurotoxicity study of platinum compounds. Effects of cisplatin versus a novel Pt(II) complex on rat cerebellum,” Neurotoxicology and Teratology. In press. View at Publisher · View at Google Scholar · View at PubMed